Security Reports > Amphastar Pharmaceuticals

Amphastar Pharmaceuticals
Data Breaches, Cyber Attacks and Security Report  ᛫  Biotech & Pharmaceuticals
Last updated August 15, 2020

Amphastar Pharmaceuticals Security Rating

/ 950

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Amphastar Pharmaceuticals is implementing good security practices.

Company Information


About Amphastar Pharmaceuticals

Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures and sells inhalation and intranasal products.

Data Breaches and Security News

Security Report for Amphastar Pharmaceuticals

Want a security rating for your organization?

This report shows a preliminary security rating for Amphastar Pharmaceuticals. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.

Get a deeper scan

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare Amphastar Pharmaceuticals's security performance with other companies